Hepatic lipase is expressed by osteoblasts and modulates bone remodeling in obesity

Bone

Volumn 62, Issue , 2014, Pages 90-98

  Bartelt, Alexander ^a,b   Beil, F Timo ^a   Müller, Brigitte ^a   Koehne, Till ^a   Yorgan, Timur A ^a   Heine, Markus ^a   Yilmaz, Tayfun ^a   Rüther, Wolfgang ^a   Heeren, Joerg ^a   Schinke, Thorsten ^a   Niemeier, Andreas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bone remodeling; Hepatic lipase; Obesity; Osteoblast

Indexed keywords

LIVER TRIACYLGLYCEROL LIPASE; OSTEOPROTEGERIN; BIOLOGICAL MARKER; LIPC PROTEIN, MOUSE; TRIACYLGLYCEROL LIPASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE REMODELING; CELL DIFFERENTIATION; CONTROLLED STUDY; CORTICAL THICKNESS (BONE); ENERGY METABOLISM; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OBESITY; OSSIFICATION; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN SECRETION; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; DEFICIENCY; ENZYMOLOGY; FEEDING BEHAVIOR; FEMUR; LIPID DIET; LUMBAR VERTEBRA; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; ORGAN SIZE; PATHOLOGY; RADIOGRAPHY; URINE;

ANIMALS; BIOLOGICAL MARKERS; BONE REMODELING; CELL DIFFERENTIATION; CELLS, CULTURED; DIET, HIGH-FAT; FEEDING BEHAVIOR; FEMUR; LIPASE; LUMBAR VERTEBRAE; MALE; MICE, INBRED C57BL; OBESITY; ORGAN SIZE; OSTEOBLASTS; OSTEOPROTEGERIN; X-RAY MICROTOMOGRAPHY;

EID: 84896897785     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.01.001     Document Type: Article

References (38)

1. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.T., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000, 100:197-207.
2. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
3. Ferron M., Wei J., Yoshizawa T., Del Fattore A., DePinho R.A., Teti A., et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010, 142:296-308.
4. Fulzele K., Riddle R.C., DiGirolamo D.J., Cao X., Wan C., Chen D., et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010, 142:309-319.
5. Ferron M., McKee M.D., Levine R.L., Ducy P., Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 2012, 50(2):568-575.
6. Bartelt A., Merkel M., Heeren J. A new, powerful player in lipoprotein metabolism: brown adipose tissue. J Mol Med 2012, 90(8):887-893. (Berl).
7. Williams K.J. Molecular processes that handle - and mishandle - dietary lipids. J Clin Invest 2008, 118:3247-3259.
8. Grey A., Banovic T., Zhu Q., Watson M., Callon K., Palmano K., et al. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol Endocrinol 2004, 18:2268-2278.
9. Nikolov I.G., Joki N., Nguyen-Khoa T., Ivanovski O., Phan O., Lacour B., et al. Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure. Bone 2010, 47:156-163.
10. Niemeier A., Niedzielska D., Secer R., Schilling A., Merkel M., Enrich C., et al. Uptake of postprandial lipoproteins into bone in vivo: impact on osteoblast function. Bone 2008, 43:230-237.
11. Niemeier A., Kassem M., Toedter K., Wendt D., Ruether W., Beisiegel U., et al. Expression of LRP1 by human osteoblasts: a mechanism for the delivery of lipoproteins and vitamin K1 to bone. J Bone Miner Res 2005, 20:283-293.
12. Schilling A.F., Schinke T., Munch C., Gebauer M., Niemeier A., Priemel M., et al. Increased bone formation in mice lacking apolipoprotein E. J Bone Miner Res 2005, 20:274-282.
13. Dieckmann M., Beil F.T., Mueller B., Bartelt A., Marshall R.P., Koehne T., et al. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo. J Bone Miner Res 2013, 28(2):236-245.
14. Bartelt A., Beil F.T., Schinke T., Roeser K., Ruether W., Heeren J., et al. Apolipoprotein E-dependent inverse regulation of vertebral bone and adipose tissue mass in C57Bl/6 mice: modulation by diet-induced obesity. Bone 2010, 47:736-745.
15. Brodeur M.R., Brissette L., Falstrault L., Moreau R. HDL3 reduces the association and modulates the metabolism of oxidized LDL by osteoblastic cells: a protection against cell death. J Cell Biochem 2008, 105:1374-1385.
16. Olivecrona G., Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 2010, 21:409-415.
17. Rao S.N., Cortese C., Miller N.E., Levy Y., Lewis B. Effects of heparin infusion on plasma lipoproteins in subjects with lipoprotein lipase deficiency. Evidence for a role of hepatic endothelial lipase in the metabolism of high-density lipoprotein subfractions in man. FEBS Lett 1982, 150:255-259.
18. Annema W., Tietge U.J. Role of hepatic lipase and endothelial lipase in high-density lipoprotein-mediated reverse cholesterol transport. Curr Atheroscler Rep 2011, 13:257-265.
19. Zambon A., Deeb S.S., Pauletto P., Crepaldi G., Brunzell J.D. Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol 2003, 14:179-189.
20. Homanics G.E., de Silva H.V., Osada J., Zhang S.H., Wong H., Borensztajn J., et al. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J Biol Chem 1995, 270:2974-2980.
21. Chiu H.K., Qian K., Ogimoto K., Morton G.J., Wisse B.E., Agrawal N., et al. Mice lacking hepatic lipase are lean and protected against diet-induced obesity and hepatic steatosis. Endocrinology 2010, 151:993-1001.
22. Yamada Y., Ando F., Shimokata H. Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men. Int J Mol Med 2007, 19:791-801.
23. Bartelt A., Weigelt C., Cherradi M.L., Niemeier A., Todter K., Heeren J., et al. Effects of adipocyte lipoprotein lipase on de novo lipogenesis and white adipose tissue browning. Biochim Biophys Acta 2013, 1831(5):934-942.
24. Choi H.Y., Dieckmann M., Herz J., Niemeier A. Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PLoS One 2009, 4:e7930.
25. Bartelt A., Orlando P., Mele C., Ligresti A., Toedter K., Scheja L., et al. Altered endocannabinoid signalling after a high-fat diet in Apoe (-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance. Diabetologia 2011, 54(11):2900-2910.
26. Wintges K., Beil F.T., Albers J., Jeschke A., Schweizer M., Claass B., et al. Impaired bone formation and increased osteoclastogenesis in mice lacking chemokine (C-C motif) ligand 5 (Ccl5). J Bone Miner Res 2013, 28:2070-2080.
27. Dempster D.W., Compston J.E., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2013, 28:2-17.
28. Bouxsein M.L., Boyd S.K., Christiansen B.A., Guldberg R.E., Jepsen K.J., Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 2010, 25:1468-1486.
29. Bartelt A., Bruns O.T., Reimer R., Hohenberg H., Ittrich H., Peldschus K., et al. Brown adipose tissue activity controls triglyceride clearance. Nat Med 2011, 17:200-205.
30. Cao J.J., Gregoire B.R., Gao H. High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice. Bone 2009, 44:1097-1104.
31. Verhoeven A.J., Jansen H. Hepatic lipase mRNA is expressed in rat and human steroidogenic organs. Biochim Biophys Acta 1994, 1211:121-124.
32. Gonzalez-Navarro H., Nong Z., Freeman L., Bensadoun A., Peterson K., Santamarina-Fojo S. Identification of mouse and human macrophages as a site of synthesis of hepatic lipase. J Lipid Res 2002, 43:671-675.
33. Tolonen S., Mikkila V., Laaksonen M., Sievanen H., Mononen N., Hernesniemi J., et al. Association of apolipoprotein E promoter polymorphisms with bone structural traits is modified by dietary saturated fat intake - the Cardiovascular Risk in Young Finns study. Bone 2011, 48:1058-1065.
34. van Tilbeurgh H., Bezzine S., Cambillau C., Verger R., Carriere F. Colipase: structure and interaction with pancreatic lipase. Biochim Biophys Acta 1999, 1441:173-184.
35. Gonzalez-Navarro H., Nong Z., Amar M.J., Shamburek R.D., Najib-Fruchart J., Paigen B.J., et al. The ligand-binding function of hepatic lipase modulates the development of atherosclerosis in transgenic mice. J Biol Chem 2004, 279:45312-45321.
36. Connelly P.W., Hegele R.A. Hepatic lipase deficiency. Crit Rev Clin Lab Sci 1998, 35:547-572.
37. Ruel I.L., Couture P., Cohn J.S., Lamarche B. Plasma metabolism of apoB-containing lipoproteins in patients with hepatic lipase deficiency. Atherosclerosis 2005, 180:355-366.
38. Isaacs A., Sayed-Tabatabaei F.A., Njajou O.T., Witteman J.C., van Duijn C.M. The -514C->T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis. J Clin Endocrinol Metab 2004, 89:3858-3863.